{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:28:01Z","timestamp":1793298481022,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00246-021-02764-1","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T09:06:47Z","timestamp":1635498407000},"page":"616-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-8706","authenticated-orcid":false,"given":"Dana B.","family":"Gal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rojahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Callis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Priest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Truty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Vatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Esplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"3","key":"2764_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacc.2013.04.044","volume":"62","author":"PJ Schwartz","year":"2013","unstructured":"Schwartz PJ, Ackerman MJ, George AL, Wilde AAM (2013) Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 62(3):169\u2013180","journal-title":"J Am Coll Cardiol"},{"key":"2764_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cardfail.2012.01.017","volume":"18","author":"SJ Kindel","year":"2012","unstructured":"Kindel SJ, Miller EM, Gupta R, Cripe LH, Hinton RB, Spicer RL et al (2012) Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. J Card Fail 18:396\u2013403","journal-title":"J Card Fail"},{"key":"2764_CR3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1542\/peds.2006-0163","volume":"118","author":"GF Cox","year":"2006","unstructured":"Cox GF, Sleeper LA, Lowe AM, Towin JA, Colan SD, Orav EJ et al (2006) Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 118:1519\u20131531","journal-title":"Pediatrics"},{"key":"2764_CR4","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1017\/S1047951116002183","volume":"27","author":"DJ Tester","year":"2017","unstructured":"Tester DJ, Ackerman MJ (2017) Evaluating the survivor or the relatives of those who do not survive: the role of genetic testing. Cardiol Young 27:S19\u2013S24","journal-title":"Cardiol Young"},{"key":"2764_CR5","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","volume":"140","author":"SE Lipshultz","year":"2019","unstructured":"Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD et al (2019) Cardiomyopathy in children: classification and diagnosis. Circulation 140:e9\u2013e68","journal-title":"Circulation"},{"key":"2764_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41436-019-0654-3","volume":"22","author":"A Ritter","year":"2019","unstructured":"Ritter A, Bedoukian E, Berger JH, Copenheaver D, Gray C, Krantz I et al (2019) Clinical utility of exome sequencing in infantile heart failure. Genet Med 22:423\u2013426","journal-title":"Genet Med"},{"key":"2764_CR7","first-page":"e1","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al (2020) AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation 142:e1\u2013e74","journal-title":"Circulation"},{"issue":"5","key":"2764_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","volume":"17","author":"SE Lincoln","year":"2015","unstructured":"Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ, Mills MA et al (2015) A systematic comparison of tradition and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn 17(5):533\u2013544","journal-title":"J Mol Diagn"},{"issue":"10","key":"2764_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY et al (2017) Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 19(10):1105\u20131117","journal-title":"Genet Med"},{"issue":"24","key":"2764_CR10","first-page":"e783","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS et al (2011) 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. Circulation 124(24):e783\u2013e831","journal-title":"Circulation"},{"key":"2764_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/CIRCGENETICS.111.960468","volume":"5","author":"JP Kaski","year":"2012","unstructured":"Kaski JP, Syrris P, Shaw A, Alapi KZ, Cordeddu V, Esteban MTT et al (2012) Prevalence of sequence variants in the RAS-Mitogen activated protein kinase signaling pathway in pre-adolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet 5:317\u2013326","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"2764_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jacc.2018.03.547","volume":"72","author":"E Arbustini","year":"2018","unstructured":"Arbustini E, Giuliani L, Di Toro A (2018) When genes, more than phenotype, identify different diseases: the case of nonsyndromic HTAA\/D. JACC 72(6):616\u2013619","journal-title":"JACC"},{"issue":"3","key":"2764_CR13","doi-asserted-by":"publisher","first-page":"e002097","DOI":"10.1161\/CIRCGEN.118.002097","volume":"11","author":"S Paige","year":"2018","unstructured":"Paige S, Saha P, Priest JR (2018) Beyond gene panels: whole exome sequencing for diagnosis of congenital heart disease. Circ Genom Precis Med 11(3):e002097","journal-title":"Circ Genom Precis Med"},{"key":"2764_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.111.090514","volume":"127","author":"MK Jensen","year":"2013","unstructured":"Jensen MK, Havndrup O, Christiansen M, Andersen PS, Diness B, Axelsson A et al (2013) Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation 127:48\u201354","journal-title":"Circulation"},{"key":"2764_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3750879","author":"J Burns","year":"2018","unstructured":"Burns J, Jean-Pierre P (2018) Disparities in the diagnosis of hypertrophic obstructive cardiomyopathy: a narrative review of current literature. Cardiol Res Pract. https:\/\/doi.org\/10.1155\/2018\/3750879","journal-title":"Cardiol Res Pract"},{"key":"2764_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1476-7120-8-54","volume":"8","author":"MR Movahed","year":"2010","unstructured":"Movahed MR, Strootman D, Bates S, Sattur S (2010) Prevalence of suspected hypertrophic cardiomyopathy or left ventricular hypertrophy based on race and gender in teenagers using screening echocardiography. Cardiovasc Ultrasound 8:54","journal-title":"Cardiovasc Ultrasound"},{"issue":"5","key":"2764_CR17","first-page":"312","volume":"18","author":"M Heradien","year":"2007","unstructured":"Heradien M, Goosen A, Brink PA, Moolman-Smook JC (2007) Race and gender representation of hypertrophic cardiomyopathy or long QT syndrome cases in a South African research setting. Cardiovasc J Afr 18(5):312\u2013315","journal-title":"Cardiovasc J Afr"},{"issue":"1","key":"2764_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamacardio.2019.4638","volume":"5","author":"LA Eberly","year":"2020","unstructured":"Eberly LA, Day SM, Ashley EA, Jacoby DL, Jefferies JL, Colan SD et al (2020) Association of race with disease expression and clinical outcomes among patients with hypertrophic cardiomyopathy. JAMA Cardiol 5(1):83\u201391","journal-title":"JAMA Cardiol"},{"issue":"4","key":"2764_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10689-019-00144-6","volume":"18","author":"MK Ndugga-Kabuye","year":"2019","unstructured":"Ndugga-Kabuye MK, Issaka RB (2019) Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European. Fam Cancer 18(4):465\u2013569","journal-title":"Fam Cancer"},{"issue":"11","key":"2764_CR20","doi-asserted-by":"publisher","first-page":"e006979","DOI":"10.1161\/CIRCIMAGING.117.006979","volume":"10","author":"L Lopez","year":"2017","unstructured":"Lopez L, Colan S, Stylianou M, Granger S, Trachtenberg F, Frommelt P et al (2017) Relationship of echocardiographic Z scores adjusted for body surface area to age, sex, race, and ethnicity: the pediatric heart network normal echocardiogram database. Circ Cardiovasc Imaging. 10(11):e006979","journal-title":"Circ Cardiovasc Imaging."},{"issue":"7","key":"2764_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMsa1507092","volume":"375","author":"AK Manrai","year":"2016","unstructured":"Manrai AK, Funke BH, Rehm HL, Olesen MS, Maron BA, Szolovits P, Margulies DM, Loscalzo J, Kohane IS (2016) Genetic misdiagnoses and the potential for health disparities. N Engl J Med 375(7):655\u2013665","journal-title":"N Engl J Med"},{"issue":"9","key":"2764_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/GIM.0b013e3181ab22aa","volume":"11","author":"S Suther","year":"2009","unstructured":"Suther S, Kiros GE (2009) Barriers to the use of genetic testing: a study of racial and ethnic disparities. Genet Med 11(9):655\u2013662","journal-title":"Genet Med"},{"issue":"2","key":"2764_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jlb\/lsv008","volume":"2","author":"AER Prince","year":"2015","unstructured":"Prince AER (2015) Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease. J Law Biosci 2(2):365\u2013395","journal-title":"J Law Biosci"},{"issue":"7","key":"2764_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/jmedgenet-2019-106425","volume":"57","author":"M Chevarin","year":"2020","unstructured":"Chevarin M, Duffourd Y, Barnard RA, Moutton S, Lecoquierre F, Daoud F et al (2020) Excess of de novo variants in genes involved in chromatin remodeling in patients with marfanoid habitus and intellectual disability. J Med Genet 57(7):466\u2013474","journal-title":"J Med Genet"},{"issue":"1","key":"2764_CR25","first-page":"64","volume":"1","author":"I Lobo","year":"2008","unstructured":"Lobo I (2008) Same genetic mutation, different genetic disease phenotype. Nat Educ 1(1):64","journal-title":"Nat Educ"},{"issue":"5","key":"2764_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1377\/hlthaff.2017.1548","volume":"37","author":"D Hauser","year":"2018","unstructured":"Hauser D, Obeng AO, Fei K, Ramos MA, Horowitz CR (2018) Views of primary care providers on testing patients for genetic risks for common chronic diseases. Health Aff (Millwood) 37(5):793\u2013800","journal-title":"Health Aff (Millwood)"},{"key":"2764_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ejmg.2018.11.029","volume":"62","author":"MJ Szego","year":"2019","unstructured":"Szego MJ, Meyn MS, Shuman C, Zlotnik Shaul R, Anderson JA, Bowdin S et al (2019) Views from the clinic: healthcare provider perspectives on whole genomic sequencing in paediatrics. Eur J Med Genet 62:350\u2013356","journal-title":"Eur J Med Genet"},{"key":"2764_CR28","doi-asserted-by":"publisher","unstructured":"Gal DB, Deuitch N, Lee SSJ, Simon RT, Char D. (2021) Parental attitudes toward clinical genomic sequencing in children with critical cardiac disease. Pediatr Crit Care Med. online ahead of print. https:\/\/doi.org\/10.1097\/PCC.0000000000002669.","DOI":"10.1097\/PCC.0000000000002669"},{"key":"2764_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12687-019-00434-7","volume":"11","author":"K Clift","year":"2020","unstructured":"Clift K, Macklin S, Halverson C, McCormick JB, Abu Dabrh AM, Hines S (2020) Patients\u2019 views on variants of uncertain significance across indications. J Community Genet 11:139\u2013145","journal-title":"J Community Genet"},{"issue":"5","key":"2764_CR30","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41436-018-0308-x","volume":"21","author":"MR Hart","year":"2019","unstructured":"Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL (2019) Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and healthcare costs from a multi-site study. Genet Med 21(5):1100\u20131110","journal-title":"Genet Med"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-021-02764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-021-02764-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-021-02764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:15:16Z","timestamp":1744193716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-021-02764-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2764"],"URL":"https:\/\/doi.org\/10.1007\/s00246-021-02764-1","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"1 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AM, TC, JG, SR, RT, MV, RLN, and EDE are employees and stockholders of Invitae. JRP is an employee and stockholder of BioMarin Pharmaceutical which has publicly disclosed early-stage therapeutic approaches to HCM. All other authors have indicated that they have no potential conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Western Independent Review Board, protocol number 1167406.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors are responsible for reported research and have approved the manuscript as submitted.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}